Back

Febuxostat and atrial fibrillation

European Heart Journal

30 March 2020
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Research Methodology Atrial Fibrillation (AF) PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Masanari Kuwabara
Masanari Kuwabara

Author

Jichi Medical University Shimotsuke , Japan

Claudio Borghi
Claudio Borghi

Author

Richard J Johnson
Richard J Johnson

Author

You may be interested in
thumbnail
Congress Presentation
Meta-analysis assessing cardiovascular outcomes with febuxostat versus allopurinol for patients with gout
27 August 2021
thumbnail
Webinar
Cardiac monitoring after ischaemic stroke: evidence and clinical practice
14 June 2021
thumbnail
Congress Presentation
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysis
20 June 2025
thumbnail
Congress Presentation
Role of inflammation and reactive oxygen species in atrial fibrillation: new therapeutic targets?
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources